![Eli Frydman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eli Frydman
Director/Board Member at LifeBond Ltd.
Eli Frydman active positions
Companies | Position | Start | End |
---|---|---|---|
LifeBond Ltd.
![]() LifeBond Ltd. Medical SpecialtiesHealth Technology LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel. | Director/Board Member | - | - |
Career history of Eli Frydman
Former positions of Eli Frydman
Companies | Position | Start | End |
---|---|---|---|
POLYPID LTD. | Director/Board Member | - | - |
Beta-O2 Technologies Ltd.
![]() Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel. | Director/Board Member | - | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | Director/Board Member | - | - |
APOSENSE LTD | Chief Operating Officer | 2002-07-31 | - |
Training of Eli Frydman
Ecole Nationale des Ponts et Chaussées | Doctorate Degree |
Tel-Aviv University | Undergraduate Degree |
Weizmann Institute of Science | Graduate Degree |
Statistics
International
Israel | 8 |
France | 2 |
Operational
Director/Board Member | 4 |
Doctorate Degree | 2 |
Chief Operating Officer | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 4 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
POLYPID LTD. | Health Technology |
Private companies | 4 |
---|---|
Aposense Ltd.
![]() Aposense Ltd. Pharmaceuticals: MajorHealth Technology Aposense Ltd. engages in the provision of proprietary conjugates. It offers platform technology which comprises the rational design of small molecular moieties with the increased affinity to the cell membranes imparting the conjugates compound with improved drug properties such as extended life span oral bioavailabity and selective at target site. The company was founded by Ilan Ziv and Jacob Gottenstein on October 9, 1996 and is headquartered in Petach-Tikva, Israel. | Health Technology |
LifeBond Ltd.
![]() LifeBond Ltd. Medical SpecialtiesHealth Technology LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel. | Health Technology |
Beta-O2 Technologies Ltd.
![]() Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel. | Health Technology |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | Health Services |
- Stock Market
- Insiders
- Eli Frydman
- Experience